Filing Details

Accession Number:
0001209191-13-038645
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-08-01 14:54:20
Reporting Period:
2013-07-30
Filing Date:
2013-08-01
Accepted Time:
2013-08-01 14:54:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
887151 Capstone Therapeutics Corp. CAPS Pharmaceutical Preparations (2834) 860585310
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
949119 Iii I Lloyd Miller 222 Lakeview Avenue
Suite 160-365
West Palm Beach FL 33401
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-07-30 1,139,000 $0.20 5,851,468 No 4 P Indirect By Trust A-4 - Lloyd I. Miller
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Trust A-4 - Lloyd I. Miller
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 472,792 Indirect By Milfam II L.P.
Common Stock 90,344 Indirect By Trust D - Lloyd I. Miller
Common Stock 545,462 Indirect By Trust C - Lloyd I. Miller
Common Stock 95,756 Indirect By Milgrat Q8
Common Stock 724,100 Indirect By LIMFAM LLC
Common Stock 58,967 Direct
Footnotes
  1. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. This filing shall not be deemed an admission that the reporting person is, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the beneficial owner of any equity securities covered by this filing.
  2. On December 5, 2012, 545,462 securities held by Milgrat (Q8) were transferred to Trust C. Such transaction only effected a change in the form of beneficial ownership without changing the reporting person's pecuniary interest in such securities and was exempt from Section 16 of the Securities Exchange Act of 1934 pursuant to Rule 16a-13.